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CD4+ T cells deficient in signaling lymphocyte activa-
tion molecule (SLAM)-associated protein (SAP) ex-
hibit a selective impairment in adhesion to antigen-
presenting B cells but not dendritic cells (DCs),
resulting in defective germinal center formation.
However, the nature of this selective adhesion defect
remained unclear. We found that whereas T cell:DC
interactions were primarily integrin dependent,
T cell:B cell interactions had both an early integrin-
dependent phase and a sustained phase that also
required SAP. We further found that the SLAM family
member CD84 was required for prolonged T cell:B
cell contact, optimal T follicular helper function, and
germinal center formation in vivo. Moreover, both
CD84 and another SLAM member, Ly108, mediated
T cell adhesion and participated in stable T cell:B
cell interactions in vitro. Our results reveal insight
into the dynamic regulation of T cell:B cell interac-
tions and identify SLAM family members as critical
components of sustained T cell:B cell adhesion
required for productive humoral immunity.
INTRODUCTION
Long-term antibody-mediated immunity depends, in part, on the
generation of germinal centers (GCs), which require T cell:B cell
cooperation for their effective formation and maintenance. Such
T cell-dependent antibody responses are initiated when CD4+
T cells are activated by antigen-presenting dendritic cells
(DCs). Once activated, these T cells deliver contact-dependent
helper signals to antigen-activated B cells, promoting their prolif-
eration and differentiation. Activated B cells that have received
such early T cell help re-enter the B cell follicle, proliferate, and
establish a GC (Allen et al., 2007). Activated antigen-specific
CD4+ T cells that have acquired CXCR5 expression also relocate
from the T cell zone into the B cell follicle and reside within thedeveloping GC to help induce and maintain GC formation; these
cells have been referred to as T follicular helper (Tfh) cells (Fazil-
leau et al., 2009).
Insight into the control of effective delivery of T cell help to B
cells for GC formation has come from analysis of patients with
X-linked lymphoproliferation (XLP) disease and its mousemodel.
Inactivating mutations in Sh2d1a, which encodes the adaptor
protein signal lymphocyte activation molecule (SLAM)-associ-
ated protein (SAP), underliemost cases of XLP. XLP is character-
ized by fulminant infectious mononucleosis, lymphoma, and
dysgammaglobulinemia (Calpe et al., 2008; Ma et al., 2007).
Analyses of SAP-deficient (Sh2d1a/) mice revealed a T cell-
intrinsic defect in humoral responses after infection or immuniza-
tion with T cell-dependent antigens, characterized by poor GC
formation, low antibody titers, and a scarcity of memory B cells
as well as long-lived plasma cells. Similar findings have been
confirmed in SAP-deficient XLP patients (Ma et al., 2007).
By using intravital imaging, we recently demonstrated that
Sh2d1a/ CD4+ T cells interact with and are activated effec-
tively by antigen-bearing DCs, resulting in proliferation, upregu-
lation of activation markers, and migration into B cell follicles,
similar to WT CD4+ T cells. However, Sh2d1a/ CD4+ T cells
fail to maintain stable conjugates with antigen-specific B cells
in vivo (Qi et al., 2008). Thus, despite their expression of key
markers characteristic of Tfh cells (CXCR5, CD40L, ICOS) and
required for B cell help, Sh2d1a/ CD4+ T cells are unable to
deliver contact-dependent signals to antigen-specific B cells.
Moreover, Sh2d1a/ CD4+ T cells do not show effective
antigen-dependent recruitment into or retention within GCs
and thus are unable to act as functional Tfh cells to help sustain
the GC reaction (Qi et al., 2008). These data implicated SAP in
adhesive processes that selectively affect durable cognate
T cell:B cell interactions required for GC formation, but not
T cell:DC contacts involved in T cell activation. Nonetheless,
howSAP contributes to effective adhesion between T andB cells
has not been elucidated.
Integrins are well characterized as critical mediators of cellular
adhesion (Burbach et al., 2007), and the decreased binding of
Sh2d1a/ T cells to antigen-activated B cells could result
from SAP-mediated effects on integrin function. Alternatively,
SAP may participate in distinct mechanisms of cell adhesionImmunity 32, 253–265, February 26, 2010 ª2010 Elsevier Inc. 253
Figure 1. Integrin-Mediated Adhesion Is Critical for Initial but Not
Prolonged T Cell:B Cell Conjugation
(A and B) Adhesion of preactivated WT and Sh2d1a/ CD4+ T cells to
recombinant ICAM2-Fc after a-CD3 stimulation (A) 10 min and (B) 15–
60 min. Results presented as the mean percent adhesion. (A) n = 3 ± SEM;
(B) n = 6 ± SEM.
(C and D) Conjugation efficiency after preincubation with blocking integrin anti-
bodies then incubation for 10–30 min with OVA323 pulsed B cells (C), mean ±
SEM frequency of CD4+CD19+ conjugates in total CD4+ events (n = 3), or (D)
DCs, mean ± SEM frequency of CD4+CD11c+ conjugates in total CD4+ events
(n = 3).
p values were calculated by paired Student’s t test; **p < 0.005.
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CD84 Mediates T Cell:B Cell Adhesioninvolving other surface adhesive receptors. SAP is almost
entirely composed of a single SH2 domain that binds to a
conserved tyrosine-based motif in the cytoplasmic tails of
SLAM family receptors, including SLAM, Ly9 (CD229), 2B4
(CD244), CRACC (CD319), Ly108 (NTB-A in human), and CD84
(Calpe et al., 2008). With the exception of 2B4, these receptors
engage in homophilic interactions and several self-associate
with high affinity (Cao et al., 2006; Yan et al., 2007). Interestingly,
there is a structural similarity between thesemolecules and CD2,
which is known to contribute to T cell adhesion (Calpe et al.,
2008). After SLAM or 2B4 engagement, SAP binds these recep-
tors and recruits the tyrosine kinase Fyn, leading to receptor
phosphorylation and initiation of signal transduction (Ma et al.,
2007). However, GC formation can be rescued by a mutant of
SAP with greatly impaired Fyn binding (Cannons et al., 2006;
McCausland et al., 2007), suggesting that SAP participates in
additional signaling pathways, perhaps downstream of other
SLAM family receptors.
To better understand how SAP influences T cell interactions
with diverse antigen-presenting cells (APC), we examined in
detail the contributions of integrins and SLAM family members254 Immunity 32, 253–265, February 26, 2010 ª2010 Elsevier Inc.to stable cell association at multiple times after cell-cell
encounter. We found that T cells initially adhered to both acti-
vated, antigen-presenting B cells and DCs in an integrin-depen-
dent manner. However, unlike long-lived T cell:DC interactions,
prolonged T cell:B cell associations had both an integrin-depen-
dent and a SAP-dependent component. We further found that
GC B cells and Tfh cells expressed high amounts of the SLAM
family members CD84 and Ly108 and that activated CD4+ cells
could adhere to CD84 and Ly108 in a SAP-dependent manner.
Importantly, Cd84/mice exhibited partial defects in antibody-
mediated responses to T cell-dependent antigens that corre-
lated with impaired Tfh cell function and decreased duration
of cognate T cell:B cell contacts as imaged in vivo. Strikingly,
simultaneous interference with homotypic intercellular binding
of both CD84 and Ly108 markedly reduced stable T cell:B cell
conjugation in vitro. Our findings provide compelling genetic
evidence that CD84 is a SAP-dependent adhesive receptor
that specifically promotes cognate T cell:B cell interactions,
and thereby is required for optimal GC formation. Moreover,
our data suggest that multiple SLAM-related receptors collec-
tively contribute to the stabilization of integrin-initiated cognate
T cell:B cell conjugates, providing new insights into the require-
ments for cell collaboration during humoral immune responses.
RESULTS
Integrin-Mediated Adhesion in SAP-Deficient CD4+
T Cells
SAP deficiency in CD4+ T cells severely impairs their ability to
form stable conjugates with cognate B cells while leaving their
antigen-specific interactions with DCs grossly intact (Qi et al.,
2008). However, the basis for this T cell-intrinsic adhesive defect
has remained undefined. Integrins are adhesive receptors that
are critical for lymphocyte trafficking into and through tissues
as well as for T cell adhesion to APCs. The predominant integrin
dimers on T cells are aLb2 (LFA-1) and a4b1 (VLA-4), which
adhere to ICAMs and VCAMs, respectively. Activation through
the T cell receptor (TCR) induces rapid increases in integrin
affinity and avidity (inside-out signaling) that promote ligand
binding, altered cell morphology, and increased adhesion (Bur-
bach et al., 2007). To examine whether SAP is involved in
inside-out signaling and integrin-mediated T cell adhesion, we
first employed a static adhesion assay that utilizes a ligand-
coated surface. When previously activated WT and Sh2d1a/
OT-II T cells were plated onto ICAM-2 or VCAM-coated surfaces,
adhesion was similarly enhanced after a-CD3 stimulation, with a
peak at 10–15 min and a steady decline thereafter (Figures 1A
and 1B and data not shown). Similar results were obtained with
naive CD4+ T cells (data not shown). These results suggest that
SAP is not required as a general regulator of integrin-mediated
adhesion and TCR-induced inside-out signaling in CD4+ T cells.
To explore the possibility that SAP could play a more subtle
role in integrin-mediated T cell adhesion to B cells, we used
live B cells in a FACS-based adhesion assay. Two time points
were analyzed after the onset of T cell:B cell interactions, one
corresponding to the peak (10 min) and the second to the
declining phase (30 min) of integrin-mediated adhesion in the
static plate-binding assay (Figure 1B). The latter time also corre-
sponds to a duration longer than SAP-deficient T cells adhere to
Figure 2. Importance of SAP in T Cell:B Cell Adhesion Is Consistent with SLAM Family Member Expression on Activated B Cells
(A) OT-II T:B cell conjugation assays were conducted with CD4+ T cells transiently transfected with DNA constructs expressing either GFP, GFP-SAP,
GFP-SAP(R78A), or GFP-SAP(R55L); n = 6, mean ± SEM frequency of CD4+CD19+ conjugates in total GFP+CD4+ events. p values were calculated by paired
Student’s t test; **p < 0.005 (see Figure S2 for immunoblot and representative FACS plot).
(B) CD11c+ splenic DCs, splenic B cells, and LPS-activated B cells were assessed for SLAM, Ly108, and CD84 expression (n = 3).
(C and D) Day 9 post-NP-OVA in alum immunization, (C) B cells or (D) Tfh (CD4+CD44+CXCR5hiPD-1hi) and non-Tfh (CD4+CD44+CXCR5loPD-1lo) cells were
evaluated for Ly108 and CD84 expression (n = 2, 2–5 mice/genotype).
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CD84 Mediates T Cell:B Cell Adhesionantigen-presenting B cells in vivo, although many WT T cells
continue their interactions well beyond this time (Okada et al.,
2005; Qi et al., 2008). Both WT and SAP-deficient OT-II T cells
showed antigen-specific, dose-dependent conjugate formation
of comparable magnitude with B cells after 10 min of incubation
(Figure 1C; Figure S1A available online). However, only WT
T cells maintained such associations at 30 min, as previously
reported (Qi et al., 2008).
SAP could still regulate a distinct late phase of T cell adhesion
to B cells that is mediated by integrins. Alternatively, SAP might
operate in a partially integrin-independent manner during this
late phase of T cell:B cell adhesion. To differentiate between
these possibilities, CD4+ T cells were preincubated with LFA-1
(CD11a)- and VLA-4 (CD49d)-blocking antibodies. At the
10 min time point (Figure 1C), this treatment largely abrogated
T cell:B cell conjugation. However, it only partially blocked conju-
gate formation between WT T and B cells at 30 min (Figure 1C).
The incomplete blocking did not result from insufficient concen-
trations of the antibody, because the same treatment reduced
T cell:DC conjugation to near background at both 10 and
30min time points (Figure 1D). Thus, sustained T cell:B cell adhe-
sion does not depend solely on LFA-1 and VLA-4, the dominant
integrins expressed by activated T cells, but rather also requires
an additional SAP-dependent pathway. These conclusions were
supported by results with antigen-activated MD4 B cells, a
condition in which Sh2d1a/ OT-II T cells showed low but
measurable conjugate pairing at 30 min (Figure S1B and S1C).
Notably, this residual adhesion of Sh2d1a/ CD4+ T cells to
MD4 B cells was completely blocked by integrin antibodies,
whereas adhesion of WT CD4+ T cells was only partially blocked,
arguing that a distinct SAP-dependent adhesion pathway oper-
ates in WT cells during prolonged T cell:B cell contact. Thus,
unlike T cell:DC adhesion, which is primarily integrin dependent,
T cell:B cell adhesion has two stages: an early integrin-depen-dent phase and a later phase that also requires SAP-dependent
pathways.
Requirements for SAP-Mediated Control
of T Cell:B Cell Adhesion
SAPbinds to tyrosine-basedmotifs in thecytoplasmic tail ofSLAM
family proteins via its SH2domain. To testwhether such binding is
required for SAP-mediated control of T cell:B cell conjugation, we
examined the SAP R55L mutant that prevents SAP from binding
SLAM (Calpe et al., 2008; Chen et al., 2004; Li et al., 2003; Ma
et al., 2007). We also evaluated the SAP R78A mutant, which
shows impaired Fyn binding but can still associate with SLAM
family members and rescue GC formation in Sh2d1a/
mice (Cannonset al., 2006;McCauslandet al., 2007).GFP-tagged
WT and mutant SAP molecules were introduced into Sh2d1a/
CD4+ Tcell blasts andassayed for conjugation efficiency between
OT-IIGFP+Tcells andactivated, peptide-pulsedBcells. In accord
with previous results, the SAP R78A mutant rescued adhesion
between Sh2d1a/ T cells and B cells as efficiently as did WT
SAP (Qi et al., 2008). However, when expressed at similar
amounts, the SAP R55L mutant failed to support T cell:B cell
conjugate formation at any peptide concentration tested (Fig-
ure 2A; Figure S2). These data suggest that interactions with
SLAM family molecules via SAP’s SH2 phosphotyrosine binding
pocket are required for SAP-mediated control of T cell:B cell
conjugation. Moreover, because the SAP R78A mutant does not
permit SLAM or 2B4 phosphorylation and signal transduction
but efficiently rescues T cell:B cell adhesion, it is likely that other
SLAM family member(s) are involved in this process.
Expression Patterns of SLAM Family Members
on Activated B and T Cells
DCs, but not B cells, actively contribute to the maintenance of
T cell:APC synapses by mechanisms involving cytoskeletalImmunity 32, 253–265, February 26, 2010 ª2010 Elsevier Inc. 255
Figure 3. Targeted Disruption of Mouse
Cd84 Gene Does Not Affect T and B Cell
Development or In Vitro Stimulation
(A) Screening for homologous recombination by
Southern blot of NcoI-digested DNA. WT allele,
10 kb. Disrupted allele, 6.5 kb. Targeting vector
and locus are shown in Figure S3A.
(B) Surface CD84 expression on WT and Cd84/
splenic B cells.
(C) Top: thymocytesstainedwitha-CD4anda-CD8.
Middle: thymocytes stained with CD1d-aGalCer
tetramers, a-CD4, a-CD24, and a-TCR-b to eval-
uate NKT cells. Bottom: splenocytes stained with
a-CD19 and a-CD4 (n = 3, 3 mice/genotype).
(D and E) WT and Cd84/ T cells were stimulated
with a-CD3 ± a-CD28 and (D) evaluated for prolif-
eration and (E) IL-2 and IFN-g production (n = 3).
(F) WT and Cd84/ B cells were stimulated for
48 hr with LPS, a-IgM, or a-CD40 and evaluated
for proliferation (n = 4).
(G)WT,Sh2d1a/, andCd84/micewere immu-
nized with the type II T cell-independent antigen,
NP-Ficoll, and assessed for NP-specific antibody
production, day 21 (n = 2, 5 mice/genotype).
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2004). However, whether T cell adhesion to DCs and B cells
involves distinct adhesive receptors has not been examined. It
is therefore of interest that we observed higher expression of
several SLAM family members, including Ly108, SLAM, and
CD84 on resting B cells, as compared to splenic CD11c+ DCs.
Activation of B cells further increased the expression of these
molecules (Figure 2B) whereas minimal changes in expression
occurred on LPS-treated CD11c+ splenic DCs (data not shown).
After immunization with a T cell-dependent protein antigen,
B220+IgDloGL-7+ GC B cells displayed increased expression of
CD84 and Ly108 relative to either B220+IgDloGL-7 or
B220+IgDhi follicular B cells (Figure 2C). Although CD4+ T cells
constitutively express CD84 and Ly108, after immunization, acti-
vated CD4+CD44+ cells expressing Tfh markers (CXCR5hiPD-1+)
from bothWT andSh2d1a/mice displayed elevated CD84 and
Ly108 expression (Figure 2D) (despite reduced Tfh cells in
Sh2d1a/ mice, see below). These findings suggested that
SLAM, CD84, and Ly108 are all potential adhesive ligand/recep-
tors involved in SAP-mediated T cell:B cell interactions and256 Immunity 32, 253–265, February 26, 2010 ª2010 Elsevier Inc.generation of humoral responses.
However, to date, analyses of SLAM-
deficient (Slamf1/) and Ly108-deficient
(Slamf6/) mice have not revealed
humoral immune defects (Howie et al.,
2005; McCausland et al., 2007; Wang
et al., 2004). We therefore chose to
examine whether CD84 is involved in
T cell:B cell interactions and the regula-
tion of antibody-mediated responses.
Generation and Phenotype
of Cd84/ Mice
A region on mouse chromosome 1 that
contains the Slam gene cluster hasbeen identified by genetic mapping as a lupus susceptibility
locus associated with the development of antinuclear anti-
bodies: 129 mice carry the lupus-prone haplotype (Chan et al.,
2006). To avoid complications from the genetic contribution of
the Slam locus from the 129 background, we generated mice
with a targeted disruption that introduced multiple stop codons
into the second exon of theCd84 gene by homologous recombi-
nation in C57BL/6J ES cells (Figure S3). Gene targeting was
confirmed by Southern analyses and the lack of CD84 expres-
sion was verified by flow cytometry (Figures 3A and 3B).
Cd84/ mice were born at expected Mendelian frequencies
and were viable, fertile, and grossly morphologically indistin-
guishable from WT littermates.
Cd84/mice showed normal thymic cellularity, normal devel-
opment of conventional CD4+ and CD8+ T cells, and typical
numbers of NKT cells, a cell population absent in SAP-deficient
mice and XLP patients (Figure 3C; Ma et al., 2007). Splenic and
lymph node cellularity and CD4+ and CD8+ T cell phenotypes
were also similar to WT mice (Figure S3B and data not shown).
TCR-mediated proliferation and cytokine secretion of purified
Figure 4. Impaired Humoral Response in the Absence of CD84
WT, Sh2d1a/, and Cd84/ mice were immunized with T cell-dependent antigen NP-OVA in alum or Ribi.
(A) GC B cell development evaluated by gating on B220+IgDlo cells; GC B cells are FashiGL-7+.
(B) Percentage of B cells with GC markers at day 4, 9, and 17 postimmunization.
(C) Splenic GCs were detected via staining with IgD and GL-7 day 9.
(D) GC number/section, day 9.
(E) GC size, day 9. *Size of the rare (2) GCs identified in Sh2d1a/ sections.
(F) NP-specific IgG ASCs in the spleen, day 9.
(G) Long-lived NP-specific plasma cell responses were measured in bone marrow, day 30.
(H) NP-specific, day 30 [NP-(30)] (see Figure S4A for high-affinity NP-specific [NP-(3)] responses).
Results are shown from mice immunized with NP-OVA in alum (A, B, and H, n = 2, 3–5 mice/genotype/time point) or NP-OVA in Ribi (C–G, n = 3, 6–8 mice/geno-
type/time point). Similar results were obtained with either adjuvant.
(I)Cd84/ orWT sorted naive CD4+CD62L+CD44lo T cells andWTB cells were cotransferred into Rag2/ hosts. Day 25 after reconstitution,Rag2/mice were
immunized with SRBCs and evaluated for GC development (see Figure S4B for antibody titers), n = 2, 4 mice/genotype/time point.
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CD84 Mediates T Cell:B Cell Adhesionsplenic Cd84/ T cells were comparable to WT T cells (Figures
3D and 3E). In addition, T cell activation by peptide-pulsed DCs
also appeared grossly normal, as shown by the fact that bothWT
OT-II andCd84/OT-II CD4+ T cells proliferated equivalently as
evaluated by CFSE dilution and secreted similar amounts of IL-2
(Figures S3C and S3D). Thus, other than a slight reduction in
IFN-g production by Cd84/ T cells in this latter assay, CD84
deficiency did not overtly alter T cell development and activation.
Although CD84 is constitutively expressed on B cells
(Figure 2B), we observed no alterations in bone marrow cellu-
larity, composition, or B cell development in Cd84/ mice (Fig-
ure 3C, bottom; Figures S3E–S3G). In response to either LPS,
a-IgM, or a-CD40 stimulation, Cd84/ B cells proliferated
comparably to WT B cells (Figure 3F). Furthermore, Cd84/
mice produced normal levels of serum NP-specific antibodies
after immunization with NP-Ficoll, a type II T cell-independentantigen (Figure 3G). Therefore, Cd84/ B cells do not exhibit
intrinsic defects in responding to antigen or mitogen stimulation
in vitro or in vivo. Together, these results suggested that the
development and function of B and T lymphocytes from
Cd84/ mice were grossly normal.
CD84 Is Required for Optimal Germinal Center
Responses
To determine whether CD84 is important for T cell-dependent
humoral responses, mice were immunized i.p. with a T cell-
dependent antigen, NP-OVA. After immunization, Cd84/
mice had reduced numbers of B220+IgDloFashiGL-7+ GC B cells
at multiple time points examined, as evaluated by flow cytometry
(Figures 4A and 4B). Histological analyses of spleens at day 9
postimmunization revealed fewer GC structures that were
also reduced in size in Cd84/ mice compared to WT miceImmunity 32, 253–265, February 26, 2010 ª2010 Elsevier Inc. 257
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CD84 Mediates T Cell:B Cell Adhesion(Figures 4C–4E). Similar results were obtainedwith either alum or
Ribi as adjuvants (Figure 4 and data not shown). We did not
observe differences in the extent of B cell apoptosis (data not
shown), suggesting that the decreases in GC B cell numbers
were not secondary to increased cell death.
In contrast to short-lived antibody-secreting cells (ASC), long-
lived plasma cells are typically derived from GC B cells and are
severely reduced in Sh2d1a/ mice (Crotty et al., 2003). These
plasma cells migrate to the bonemarrow and continue to secrete
antibody for extended periods of time (Allen et al., 2007).
Although both Sh2d1a/ and Cd84/ mice developed a
considerable NP-specific ASC response at day 9 (Figure 4F),
they had fewer NP-specific ASCs in the bone marrow 30 days
postimmunization (Figure 4G). This reduction in long-lived
plasma cell generation correlated with lower total amounts of
NP-specific antibodies in serum at day 30 (Figure 4H). Interest-
ingly, Cd84/ mice did develop high-affinity NP-specific
antibodies, albeit at lower titers than WT mice (Figure S4A).
Together, these data demonstrate that CD84 is required for
maximal GC formation and T cell-dependent antibody produc-
tion. However, in absolute magnitude, the defects displayed by
Cd84/ mice were intermediate relative to the robust WT
responses and the extremely poor responses of Sh2d1a/
mice.
Cd84/ Mice Have T Cell-Intrinsic Defects
A large body of data indicates that the humoral defects in
Sh2d1a/mice are T cell intrinsic (Calpe et al., 2008; Schwartz-
berg et al., 2009). To determine whether there was a T cell-
intrinsic component to the impaired GC response in Cd84/
mice, we reconstituted Rag2/mice with either WT or Cd84/
CD4+ T cells along with WT B cells, waited 25 days to minimize
effects of homeostasic expansion, and immunized with sheep
red blood cells (SRBCs). Under these conditions, WT T cells
provided help to generate robust GC responses. However,
Cd84/ T cells were less efficient at supporting GC and long-
term antibody responses (Figure 4I; Figure S4B). Similar results
were obtained with adoptive transfer of WT, Sh2d1a/, or
Cd84/ OT-II GFP+ CD4+ T cells into SAP-deficient hosts that
were subsequently immunized with NP-OVA. Although Cd84/
OT-II T cells rescued some GC formation, the extent of this
rescue was reduced relative to WT cell transfers (Figure S4C).
Although these results do not rule out a B cell component to
this phenotype, and indeed we would expect there to be one
because CD84 is its own ligand, our results demonstrate that
Cd84/ T cells have an intrinsic defect in supporting help for
GC formation.
Evaluation of Tfh Cell Differentiation and Function
To determine whether the suboptimal GC response observed in
Cd84/ mice was a result of impaired Tfh cell differentiation or
function, we evaluated the expression of the Tfh cell markers
CXCR5 and PD-1 on activated T cells in WT, Sh2d1a/, or
Cd84/mice after immunization. Both Sh2d1a/ and Cd84/
CD4+ T cells were able to upregulate Tfh cell markers early in the
response (day 4). Although there was a reduction in the
percentage of cells expressing Tfh cell markers in Sh2d1a/
mice, this reduction was much less severe than the subsequent
defect in GC formation (Figure 4A). However, at time points when258 Immunity 32, 253–265, February 26, 2010 ª2010 Elsevier Inc.GC formation was maximal (days 7–9), there was a clear
decrease in CD4+ T cells expressing Tfh cell markers in both
Sh2d1a/ and Cd84/ mice (Figures 5A and 5B). Similar
results were observed when WT, Sh2d1a/, or Cd84/ OT-II
GFP+ T cells were transferred into Sh2d1a/ hosts and Tfh
cell markers evaluated after NP-OVA immunization (Figure 5C).
In these experiments, we observed no differences between the
genotypes early in the response, yet clear differences in Tfh cells
at the time of maximal GC formation. These results are reminis-
cent of our previous findings where Sh2d1a/ CD4+ T cells
initially expressed markers consistent with Tfh cell differentiation
yet were unable to deliver contact-dependent B cell help and
were neither efficiently recruited into nor retained within the GC
(Qi et al., 2008). Interestingly, relative to WT cells there was
a reduction in the percentage of both Sh2d1a/ and Cd84/
OT-II GFP+ T cells producing IL-21 (Figure 5D), a cytokine that
is highly expressed by Tfh cells and serves as a potent B cell
stimulator (Fazilleau et al., 2009). Similar results were observed
with T cells from immunized WT, Sh2d1a/, and Cd84/
mice (Figure S5). Although IL-21 is produced by multiple effector
CD4+ T cell lineages, IL-21 is highly expressed by Tfh cells
(Figure S5; Fazilleau et al., 2009; Johnston et al., 2009; Nurieva
et al., 2009; Yu et al., 2009), suggesting that theremay be defects
in Tfh cell differentiation and/or function in the absence of either
SAP or CD84. Thus, despite the initial expression of activation
markers consistent with Tfh cell development, both Sh2d1a/
and Cd84/ mice have reduced numbers of Tfh cells at the
time of maximal GC development, suggesting a defect in final
Tfh cell differentiation or maintenance.
Cd84/ CD4+ T Cells Are Defective
in Adhesion to Cognate B Cells
To examine whether CD84, like SAP, contributes to GC forma-
tion by affecting the stability of T cell:B cell interactions, we eval-
uated conjugation between activated OT-II CD4+ T cells and
OVA323 pulsed DCs or LPS-activated B cells in vitro. Dose-
dependent increases in T cell:DC conjugate frequency were
observed with both WT and Cd84/ OT-II T cells (Figure 6A).
Similar results were obtained with naive OT-II T cells (data not
shown). However, when B cells were used as the APCs,
Cd84/ OT-II T cells were significantly less efficient (*p < 0.05;
1 mg/ml, **p < 0.005; 10 mg/ml) in forming conjugates as
compared to their WT counterparts (Figure 6B). Thus, CD84
expression on T cells contributes to optimal antigen-specific
T cell:B cell adhesion in vitro. Nonetheless, Cd84/ T cells
were better at forming conjugates with B cells than Sh2d1a/
T cells, especially at higher peptide concentrations (compare
Figures 6B and 7E).
To determine whether these observations apply in vivo, we
examined the dynamics of cognate T cell:B cell interactions via
2-photon intravital imaging. WT, Cd84/, or Sh2d1a/ OT-II
GFP+ T cells were transferred along with WT MD4 CFP+ B cells
into recipient mice that were subsequently immunized with
HEL-OVA conjugate antigen. Under these conditions,
Sh2d1a/OT-II T cells typically made contacts withMD4B cells
that mostly lasted less than 10 min and they were incapable of
forming long-lasting conjugates with these B cells (>30min dura-
tion), in contrast to their WT counterparts (Figure 6C; Movie S1;
Qi et al., 2008). Although the bulk of the contacts involving
Figure 5. Evaluation of Tfh Cells
(A and B) Flow cytometric analysis of cells expressing Tfh markers from WT,
Sh2d1a/, and Cd84/mice at day 4 and 9 postimmunization with NP-OVA
in alum.
(A) Representative FACS plots (gated on CD4+ cells).
(B) Percent Tfh cells, n = 2, 2–5 mice/genotype/time point.
(C and D) WT, Sh2d1a/, or Cd84/ OT-II GFP+ T cells were transferred into
Sh2d1a/ hosts subsequently immunized with NP-OVA in alum (n = 2, 3mice/
genotype/time point).
(C) Number of WT, Sh2d1a/, or Cd84/ OT-II GFP+ Tfh
(CD4+CXCR5hiPD-1hi) cells day 4 and 7 postimmunization.
(D) IL-21 production from WT, Sh2d1a/, or Cd84/ OT-II GFP+ cells (see
Figure S5 for Tfh cell IL-21 production).
Immunity
CD84 Mediates T Cell:B Cell AdhesionSAP-deficient T cells lasted less than 3 min, these cell contacts
still lasted longer on average than noncognate interactions (Qi
et al., 2008). Cd84/ OT-II T cells, however, exhibited an inter-
mediate phenotype. Relative to WT, Cd84/ OT-II T cells had a
reduced ability to form the longest-lasting conjugates seen with
WT T cells and MD4 B cells, although they were more efficient
than SAP-deficient T cells in maintaining contacts with B cells
lasting longer than 10 min. These findings are consistent with
the notion that CD84 on T cells contributes to the efficiency of
cognate adhesion with B cells in a physiologic lymphoid environ-
ment. This intermediate defect in adhesion to B cells correlated
with a reduced capacity ofCd84/OT-II T cells to promoteMD4
B cell clonal expansion in this cotransfer system (Figure 6D).
Thus, our results suggest that CD84, like SAP, contributes to
a normal GC response by promoting cognate T cell:B cell inter-
actions and the efficient delivery of contact-dependent T cell
help to B cells required for B cell expansion and GC formation.
CD84 and Ly108 Are Adhesive Receptors that
Contribute to Sustained T Cell:B Cell Adhesion
The intermediate phenotype observed with Cd84/ CD4+
T cells relative to WT and Sh2d1a/ CD4+ T cells both in vitro
and in vivo suggested that other SLAM family receptors partici-
pate in SAP-dependent regulation of T cell:B cell interactions.
Ly108 is an intriguing candidate, because like CD84, it shows
homophilic interactions, self-associates with high affinity (Cao
et al., 2006; Yan et al., 2007), and is upregulated on GC B cells
and Tfh cells (Figures 2C and 2E). Intriguingly, Ly108 was ex-
pressed slightly higher on Cd84/ compared to WT Tfh cells,
suggesting partial functional compensation between these
SLAM family members (Figure 7A). To examine whether CD84
and Ly108 can directly mediate adhesion, we compared binding
of preactivated WT and Sh2d1a/ CD4+ T cells to recombinant
CD84, Ly108, and ICAM-2. WT CD4+ T cells bound to plastic
surfaces coated with any of the three ligands. However, despite
similar Ly108 and CD84 expression on WT and Sh2d1a/ CD4+
T cells, adhesion to CD84 or Ly108 but not ICAM-2 was clearly
decreased in Sh2d1a/ cells (Figure 7B). Stimulation of WT
and Sh2d1a/CD4+ T cells with a-CD3 had no effect on binding
to either CD84 or Ly108 at multiple time points examined, sug-
gesting that their adhesion does not change upon TCR engage-
ment (data not shown).
To evaluate the possibility that both CD84 and Ly108
contribute to stabilization of T cell:B cell interactions, CD4+
T cell blasts were preincubated with either a-CD84 or a-Ly108
prior to conjugate formation. Addition of a-CD84 or a-Ly108
significantly (p < 0.05) reduced T cell:B cell conjugate efficiency
at 30 min but not at 10 min (Figure 7C), yet did not appreciably
affect T cell:DC conjugation at any time point tested (Figure 7D).
Together, our results provide evidence that both CD84 and
Ly108 can function as SAP-dependent adhesion receptors that
specifically promote sustained T cell:B cell conjugation.
CD84 and Ly108 Cooperate in Promoting T Cell:B
Cell Conjugation
The ability of CD4+ T cells to bind either CD84 or Ly108 in a SAP-
dependent manner raises the interesting possibility that coordi-
nated action by CD84 and Ly108 contributes to the profound
defect in prolonged T cell:B cell adhesion exhibited byImmunity 32, 253–265, February 26, 2010 ª2010 Elsevier Inc. 259
Figure 6. Cd84/ OT-II T Cells Are Defective in Adhesion to Cognate B Cells
(A and B) Conjugation efficiency of preactivated WT and Cd84/ OT-II T cells with OVA323 pulsed splenic (A) CD11c
+ DCs, mean ± SEM frequency of
CD4+CD11c+ conjugates in total CD4+ events (n = 4, representative FACS plots, right panel), (B) LPS-activated B cells, mean ± SEM frequency of
CD4+CD19+ conjugates in total CD4+ events (n = 4, representative FACS plots, right panel) (p values were calculated by paired Student’s t text; *p < 0.05,
**p < 0.005).
(C) In vivo contact durations between T cells of indicated genotypes and MD4 B cells as measured by intravital microscopy between 60 and 72 hr after
immunization with HEL-OVA in alum. Individual contact durations (left) and their distribution (right) are shown. A total of 125, 120, and 49 contacts pooled
from 3 experiments for WT, Cd84/, and Sh2d1a/ T cells, respectively. Mean contact times: WT, 14.5 ± 1.2 min; Cd84/, 8.5 ± 2.1 min; Sh2d1a/, 3.5 ±
1.6 min. The p values were calculated by nonparametric one-way ANOVA.
(D) Recovery of MD4 B cells from draining lymph nodes 96 hr post-HEL-OVA immunization with or without exogenous OT-II T cells of indicated genotypes.
Each symbol represents one of four mice/group. Data from one of three experiments with similar results are shown.
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CD84 Mediates T Cell:B Cell AdhesionSh2d1a/ T cells. Ideally, this could be tested in mice deficient
in both CD84 and Ly108. However, these two genes are located
next to each other onmouse chromosome 1,making it difficult to
generate the desired double deficiency. To overcome this
obstacle, we took advantage of the homophilic properties of
both CD84 and Ly108 molecules (Cao et al., 2006; Yan et al.,
2007). We paired Cd84/ CD4+ T cells and Ly108-deficient
(Slamf6/) B cells in the in vitro conjugate assay, thus creating
a functional ‘‘T cell:B cell double mutant’’ where neither homo-
philic receptor could be engaged in trans between the two
lymphocyte types (see diagrams in Figures 7E and 7F). Because
Slamf6/ mice were generated on a 129 background, their
SLAM locus expresses the 129 alleles, even though they are
partially backcrossed to C57Bl/6 mice (confirmed by staining
for Ly9 polymorphic epitopes, data not shown). We therefore
used B cells isolated from Sle.1b congenic mice (C57Bl/6 mice
expressing the 129 SLAM locus) as controls in this assay (Wand-260 Immunity 32, 253–265, February 26, 2010 ª2010 Elsevier Inc.strat et al., 2004). Sh2d1a/ OT-II T cells failed to form stable
conjugates with control Sle.1b congenic B cells while Cd84/
OT-II T cells again demonstrated reduced conjugate formation
(Figure 7E). WT OT-II T cells formed conjugates with Sle.1b con-
genic B cells; however, the percentage formed was slightly
reduced relative to B6 activated B cells (compare Figure 7E to
Figures 1C and 1D), despite similar expression of SLAM,
CD84, and Ly108 (data not shown). Strikingly, although WT
OT-II T cells formed conjugates with LPS-activated Slamf6/
B cells in a similar dose-dependent manner to that seen with
Sle.1b congenic B cells, Cd84/ OT-II T cells formed very few
conjugates with Slamf6/ B cells at any peptide concentration
examined, analogous to the defect observed with SAP-deficient
OT-II T cells (Figure 7F; Figure S6). Thus, multiple SLAM family
members collectively contribute to T cell:B cell conjugation
in vitro and may functionally compensate for each other during
T cell:B cell lymphocyte interactions.
Figure 7. CD84 and Ly108 Are Adhesive Receptors and Contribute to Long-Lived Stable T Cell:B Cell Conjugates
(A) Ly108 expresssion on Tfh (CD4+CXCR5hiPD-1hi) cells from WT and Cd84/ mice post-NP-OVA in alum immunization.
(B) Evaluation of preactivated WT and Sh2d1a/ T cell adhesion to recombinant ICAM2-Fc, Ly108-Fc, and CD84-myc.HIS assessed for 30 min (n = 4).
(C and D) Conjugation efficiency of blasted WT OT-II T cells, preincubated with a-CD84 or a-Ly108, with OVA323-pulsed LPS-activated B cells (C), mean ± SEM
frequency of CD4+CD19+ conjugates in total CD4+ events (n = 4), or DCs (D), mean ± SEM frequency of CD4+CD11c+ conjugates in total CD4+ events (n = 3).
(E and F) Conjugation frequencies of preactivated WT, Sh2d1a/, and Cd84/OT-II T cells with OVA323-pulsed LPS-activated B cells for 30 min from (E) Sle.1b
congenic or (F) Slamf6/ mice, mean ± SEM frequency of CD4+CD19+ conjugates in total CD4+ events, n = 3 (see Figure S6 for representative FACS plot).
p values were calculated by paired Student’s t text; *p < 0.05, **p < 0.005.
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Proper functioning of the adaptive immune system requires
effective intercellular cooperation involving direct physical inter-
actions among lymphocytes and myeloid lineage cells. Our
previous studies revealed that the small adaptor protein SAP
plays a critical role in GC formation and that a major effect of
SAP deficiency is to limit the duration of effective T cell:B cell
contact required for delivery of helper signals, without a compa-
rable effect on initiation of T cell immunity involving DCs (Qi et al.,
2008). Here we explored the mechanistic basis for these obser-vations and provide evidence that although integrins, in partic-
ular LFA-1 and VLA-4, are major adhesive receptors involved
in stable, antigen-dependent T cell:DC interactions and early
T cell:B cell associations, sustained T cell:B cell contacts are
also dependent on SAP and the associated SLAM family
member CD84. Thus, without the proper functioning of SAP
and SLAM family receptors, integrin-dependent interactions
with B cells are insufficient to sustain effective delivery of T cell
help required for GC formation.
SLAM familymembers are a series of receptors on hematopoi-
etic cells that bind to the adaptor SAP to initiate downstreamImmunity 32, 253–265, February 26, 2010 ª2010 Elsevier Inc. 261
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CD84 Mediates T Cell:B Cell Adhesionsignaling cascades. The homophilic nature of many of these
receptors, combined with high-affinity binding (Cao et al.,
2006; Yan et al., 2007) and homology to CD2 (Calpe et al.,
2008), suggests potential roles as cell adhesion receptors,
although direct demonstration of such functionality has been
limited (Howie et al., 2002; Nanda et al., 2005). Our results
provide clear evidence that T cells adhere to CD84 in a SAP-
dependent manner. Moreover, the observation that Cd84/
T cells display a reduced ability to support GC formation
suggests that CD84 is critical for the sustained T cell:B cell
interactions required for this process. These data furthermore
indicate that the initiation and the maintenance phases of
stable T cell:B cell interactions have distinct requirements for
different receptor families, with the initial phase primarily
controlled by integrins and the later phase also requiring SAP
and SLAM family members. The requirement for SAP and
SLAM family members in this sustained phase is therefore a
major difference between T cell interactions with antigen-pre-
senting DCs versus B cells. Our results further raise the possi-
bility that these differences result in part from the selective
expression patterns of the SLAM family receptors on these
distinct cell populations.
Our study provides evidence that deficiency of a specific
SLAM family receptor, CD84, partially phenocopies the humoral
defects seen in the absence of SAP by affecting T cell:B cell
adhesion and GC formation. Of note, both T cell:B cell interac-
tions and GC formation are markedly improved when Sh2d1a/
cells are reconstituted with SAP R78A mutant (Cannons et al.,
2006; McCausland et al., 2007; Qi et al., 2008). Interestingly,
CD84 can be tyrosine phosphorylated in SAP-deficient T cells
from XLP patients (Tangye et al., 2003), raising the possibility
that CD84 does not require SAP R78-mediated Fyn recruitment
for receptor tyrosine phosphorylation, while still requiring SAP for
downstream signal transduction.
The partial nature of the humoral defects inCd84/mice sug-
gested potential collaboration between SLAM family members.
Indeed, we found that Ly108 is also a SAP-dependent adhesive
receptor that contributes to T cell:B cell conjugation in vitro.
Interestingly, Ly108 phosphorylation, albeit greatly reduced, is
detected in thymocytes expressing the SAP R78A mutant, indi-
cating that Ly108 can undergo some tyrosine phosphorylation
independent of direct SAP R78-mediated Fyn contact (Zhong
and Veillette, 2008). This study also demonstrated Vav1 phos-
phorylation in response to Ly108 engagement (Zhong and Veil-
lette, 2008). Vav proteins are central mediators of cytoskeletal
reorganization that act as exchange factors for the Rho family
GTPases, Cdc42, Rac, and Rho (Burbach et al., 2007). Previous
data from NK cells demonstrated cooperative synergistic
binding to insect target cells expressing ICAM-1 and CD48 (the
ligand for 2B4) (Barber and Long, 2003; Bryceson et al., 2005)
leading to increased Vav phosphorylation (Riteau et al., 2003).
Thus, NK cell:target cell and T cell:B cell contacts provide inter-
esting parallels where potential signaling cross-talk between in-
tegrins and SLAM-related receptors may help coordinate cyto-
skeletal rearrangement and adhesion. Although we have not
seen evidence for ‘‘inside-out signaling’’ to integrins from these
SLAM family receptors in our assays, it is possible that such
cross-talk also adds to amplification of adhesion processes or
is required for sustained adhesion in vivo.262 Immunity 32, 253–265, February 26, 2010 ª2010 Elsevier Inc.Our in vitro data support direct roles for both CD84 and Ly108
in promoting and/or stabilizing prolonged T cell:B cell contacts.
These results are reminiscent of those recently observed for NKT
cell development where chimeric mice that were functional
double knockouts revealed that both SLAM and Ly108 partici-
pate in this process and are partially redundant, despite minimal
to no defects in NKT cell development in gene-targeted mice
affecting the individual receptors (Griewank et al., 2007).
Although it is plausible that other SLAM family members,
including SLAM and Ly9, contribute to stable T cell:B cell inter-
actions, adhesion between Cd84/ CD4+ T cells and Slamf6/
B cells in vitro is as defective as that seen in the absence of SAP,
suggesting that these are major SLAM family members involved
in T cell:B cell interactions required for delivery of T cell help and
productive GC formation.
These latter findings are consistent with our data showing that
both CD84 and Ly108 are highly expressed on both GC B cells
and CD4 Tfh cells, as well as previous gene-expression studies
showing that Tfhcells expresshigh levelsofSAPandCD84 (Chta-
nova et al., 2004; Vinuesa et al., 2005). Tfh cells are recognized as
a specialized subclass of effector CD4+ T cells that reside within
GCs and are critical for their formation andmaintenance. In addi-
tion to expressing molecules important for GC development,
including CD40L and ICOS, this effector population is character-
ized by IL-21 production and Bcl-6 expression (Fazilleau et al.,
2009; Johnston et al., 2009; Nurieva et al., 2009; Yu et al.,
2009). Although Sh2d1a/ mice have T cell-intrinsic defects in
GC formation, the effects of SAP deficiency on Tfh cell differenti-
ation are less clear.Whereas SAP deficiency decreased percent-
ages of Tfh cells in a model of chronic autoimmunity (Linterman
et al., 2009), we found, by using intact animals and cell transfers,
that at early time points postimmunization, Sh2d1a/- and
Cd84/-activated CD4+ T cells can upregulate the Tfh cell
markers CXCR5 and PD-1. However, at the time of maximal GC
formation, Tfh cells are reduced in the absence of either SAP or
CD84. Moreover, we observed a reduction in IL-21 production
from Sh2d1a/ and Cd84/ CD4+ T cells. Because Tfh cells
are associatedwith high IL-21 expression, these findings support
the idea that full differentiation of functional Tfh cells may require
sustained T cell:B cell contact (Haynes et al., 2007; Nurieva et al.,
2008; Qi et al., 2008). Our observations therefore raise the possi-
bility that Tfh cell differentiation is amultistep process and it is the
later phase that is most affected by SAP deficiency.
Recent data indicate that SLAM family members contribute to
the development of autoimmunity and increased antinuclear
antibody production (Chan et al., 2006). Thus, it is intriguing
that we observed differences in conjugate efficiencies between
B6WT CD4+ T cells and B cells isolated from B6 and Sle.1b con-
genic mice despite comparable surface expression of SLAM
family members. These results highlight the importance of the
genetic background of mice deficient in SLAM family members
for evaluating their function. It is also of note that SAP deficiency
ameliorates disease in several models of autoimmunity (Chan
et al., 2006; Linterman et al., 2009). Although the use of SAP-
based therapeutics would be fraught with potential complica-
tions from EBV or malignant B cells, the milder defects observed
in Cd84/ mice raise the possibility of CD84 as an attractive
alternative therapeutic target for autoimmune disorders with a
humoral component.
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cell development and function (Calpe et al., 2008; Ma et al.,
2007). Our results provide evidence that a SLAM family member,
CD84, is involved in GC formation and the generation of humoral
immunity, and moreover, suggest that multiple family members
cooperate in this process. Our results further indicate that
SLAM family members participate in these processes by specif-
ically affecting adhesion between lymphocytes as opposed
to binding between T cells and other cell types involved in
MHC-dependent antigen presentation. It is thus highly intriguing
that many of the phenotypes of Sh2d1a/ mice and SAP-defi-
cient XLP patients are related to cellular interactions that occur
specifically between lymphocytes, including impaired T and
NK cell killing of virally infected or transformed B lymphocytes,
impaired T cell help for B cells, and impaired generation of
‘‘innate’’ T lymphocytes selected by recognition of ligand on
other thymocytes, such as is the case for NKT cells (Qi et al.,
2008; Schwartzberg et al., 2009). By providing support for
a direct role of SLAM family members in lymphocyte:lymphocyte
interactions, our results provide a conceptual framework for
understanding these diverse phenotypes.
EXPERIMENTAL PROCEDURES
Mice
Cd84 DNA was isolated from a C57BL/6J BAC clone and inserted into pPNT
double loxP so that the second exon of the Cd84 gene encoding the IgV
ecotodomain of CD84 was replaced with two stop codons followed by
PGK-Neo. The targeting vector was linearized with NotI and electroporated
into HGTC-8 C57BL/6J ESCs (Cheng et al., 2004), which were selected in
G418 and FIAU. DNA isolated from ESC clones were screened by Southern
blot with NcoI digestion to generate a 10 kb band from the endogenous
Cd84 allele and a 6.5 kb band from the targeted allele. Single integration
was confirmed by screening for Neo. Cd84+/ ESC clones were injected
into Balb/c blastocytes and chimeric mice bred to C57BL/6J mice to generate
pure C57BL/6J F1 mice that were either bred to homozygosity or bred to
C57BL/6J for one further generation before additional breeding. Sh2d1a/
mice (Czar et al., 2001) were backcrossed to B6 for 10 generations.
C57BL/6, Rag2/, Ub-GFP-expressing, CFP-expressing transgenic, HEL-
specific Ig-transgenic MD4, and OVA323–339-specific TCR-transgenic OT-II
mice were purchased from Jackson. Slamf6/ mice on a mixed 129 3 B6
F1 were purchased from the MMRRC and were backcrossed to C57Bl/6
2 generations prior to breeding to homozygosity. Sle.1b congenic mice
were described (Wandstrat et al., 2004). All mice were maintained under
specific-pathogen-free conditions and used in accordance of NIH institutional
guidelines for animal welfare.
Adhesion Assay
96-well Nunc MaxiSorp plates were coated with mouse rICAM-2/Fc
(0.3 mg/well), rVCAM/Fc (0.3 mg/well), rLy108/Fc (0.6 mg/well) (R&D), or
rCD84-myc/HIS-tagged protein (0.6 mg/well). Assays were performed with
preactivated CD4+ T cells as described (Finkelstein et al., 2005).
Generation and Purification of Recombinant CD84
The portion of the gene encoding the extracellular domain of CD84 was ampli-
fied by RT-PCR from C57Bl/6 splenic RNA and subcloned into pcDNA3.1/
myc.His (Invitrogen). Constructs were transiently transfected into CHO cells
with Lipofectamine 2000 (Invitrogen) and expression confirmed by intracel-
lular staining. CD84-myc.His-tagged protein was purified with the Probond
Ni NTA purification system for His-tagged recombinant proteins (Invitrogen)
and concentrated via centricon YM-30 (Amicon) at 5000G. Recombinant
protein was dialysed against PBS and purification evaluated by SDS-PAGE
stained with Coomassie and immunoblotting with a-myc (Cell Signaling
Technology).Proliferation, Differentiation, and Cytokine Production
T cells purified by mouse T cell enrichment column (R&D) were stimulated with
immobilized a-CD3 (1 mg/ml) ± a-CD28 (5 mg/ml). Proliferation was evaluated
by [3H]-thymidine pulse 24–72 hr poststimulation. Supernatants were isolated
at indicated times for cytokine analysis via ELISA (R&D). CD4+ T cells were
purified by negative selection with CD4 isolation kits (Miltenyi Biotec). To
isolate DCs, spleens were digested with Liberase CI (Roche) and purified
with CD11c microbeads (Miltenyi Biotec). Lineage differentiation was evalu-
ated by restimulating cells with PMA (10 ng/ml) and ionomycin (1 mg/ml) for
5 hr and staining for intracellular cytokine production with a-IFN-g antibody
(BD Biosciences) while IL-21 was detected with IL-21RFc (R&D) (Suto et al.,
2008). Polyclonal or MD4 B cells were isolated by naive CD43 B cell isolation
kit (Miltenyi Biotec). B cells were stimulated with varying concentrations of
LPS, soluble a-CD40 (BD Bioscience), or a-IgM (Jackson ImmunoResearch)
and evaluated for proliferation via [3H]-thymidine incorporation.
Immunization, ELISAs, and ELISPOT
For T cell-dependent responses, mice were injected i.p. with 100 mg of
NP-OVA (Biosearch Technologies Inc.) in Ribi (Corixa) or alum (Pierce) or
immunized with SRBCs (Colorado Serum Company). For T cell-independent
responses, mice were immunized with 100 mg NP-Ficoll (Biosearch Technolo-
gies Inc.) in 0.2 ml HBSS. ELISAs were performed with 96-well flat-bottom
Immuno Plates (Nunc) (Cannons et al., 2006). Goat a-mouse IgG+M+A (Caltag
Laboratories) or [NP-(18)-BSA] was used to capture total or NP-specific
antibody-secreting cell ELISPOTs (Cannons et al., 2006).
Flow Cytometry and Microscopy
Antibodies were from the following sources: anti-Fas, GL-7, IgMa, CXCR5,
CD44, CD24, TCR-b (BD Bioscience), IgD (SouthernBiotech), CD84, SLAM
(Biolegend), Ly108, B220, CD19, CD4, CD11c, CD11a, CD49d, PD-1
(eBioscience). Flow cytometry data analysis was performed with Flojo soft-
ware (Treestar). GCs were identified as described (Cannons et al., 2006).
The number of GCs (GL-7+IgD areas in the follicular mantle) were determined
by systematic examination of the entire spleen section through themicroscope
ocular. GC images were captured at 203 and Zeiss AIM (v 4.2) software was
employed to determine GC area in mm2.
In Vitro Cell Conjugation Assay
OT-II T cells (5 3 105/well) were incubated for 10–30 min (37C) in 96-well
U-bottom plates with DCs (106/well) or LPS-activated B cells (2 3 106/well)
pulsed with antigen OVA323 (AnaSpec) or antigen-(HEL-OVA or HEL-BSA)-
activated MD4 B cells (23 106/well). Conjugate frequencies were enumerated
by flow cytometry after the cell mixture was stained at 4C for CD4, CD11c,
and CD19. For blocking experiments, T cells were preincubated for 30 min
at 4C prior to conjugation with 20 mg/ml of a-CD11a, a-CD49d, a-CD84, or
a-Ly108, which were included throughout the conjugation. Transfection of
CD4+ T cells was performed via Amaxa nucleofection, as previously described
(Qi et al., 2008).
Adoptive Transfer, Intravital Imaging,
and Assay of B Cell Expansion In Vivo
A total of 1 3 105 OT-II T cells of a given genotype were transferred into
Sh2d1a/ recipients that were then immunized subcutaneously with 50 mg
of NP-OVA in alum. For intravital imaging, 53 104 T cells of one given genotype
and 2 3 105 B cells/mouse were cotransferred into naive B6 or CD45.1 con-
genic B6 recipients, which were then immunized with 20–30 mg chemical
conjugates of OVA and HEL or BSA and HEL mixed in alum and 0.2 mg LPS.
Intravital imaging of the draining lymph node was conducted 60–72 hr later,
and MD4 B cell expansion was measured by flow cytometry 96 hr postimmu-
nization. Hardware and software methods used for imaging data acquisition
and analysis have been described (Qi et al., 2008).
Statistical Analysis
For intravital imaging analysis the nonparametric Mann-Whitney rank sum test
was used when data points exhibited highly skewed and non-Gaussian distri-
butions. For Gaussian-like distribution, t tests were used to compare endpoint
means of different groups. Statistical differences between analyzed groups
were calculated with the paired Student’s t test. Values of p < 0.05 areImmunity 32, 253–265, February 26, 2010 ª2010 Elsevier Inc. 263
Immunity
CD84 Mediates T Cell:B Cell Adhesionconsidered significant. Calculation and graphing were done in Prism (Graph-
Pad) and Excel (Microsoft).
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